Aspects of AI related information that either differed between the subgroups or were misunderstood by one or both subgroups included 1 knowledge of AI or tamoxifen prior to cancer diagnosis, 2 use of online resources, 3 misconceptions about estrogen, hormone replacement therapies and AI related symptoms, and 4 risk perception and the meaning and use of recur
Aspects of AI related information that either differed between the subgroups or were misunderstood by one or both subgroups included 1 knowledge of AI or tamoxifen prior to cancer diagnosis, 2 use of online resources, 3 misconceptions about estrogen, hormone replacement therapies and AI related symptoms, and 4 risk perception and the meaning and use of recur